IMSE 311 – Week 10: Autoimmunity and Tumor Immunology

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/293

encourage image

There's no tags or description

Looks like no tags are added yet.

294 Terms

1
New cards

Autoimmunity

Conditions in which organ or tissue damage results from autoantibodies or autoreactive cells.

2
New cards

Self-antigens

Antigens produced by the body's own cells that may become targets of autoimmune responses.

3
New cards

Self-tolerance

Ability of the immune system to recognize self-antigens as non-threatening while recognizing foreign antigens as threats.

4
New cards

Central tolerance

Mechanism that removes or destroys self-reactive B and T lymphocytes during development.

5
New cards

Where does central tolerance occur?

Bone marrow and thymus.

6
New cards

Peripheral tolerance

Mechanism that controls self-reactive lymphocytes that escape central tolerance.

7
New cards

Where does peripheral tolerance occur?

Secondary lymphoid organs.

8
New cards

Which cells primarily mediate peripheral tolerance?

T-regulatory cells.

9
New cards

Main function of T-regulatory cells

Suppress immune responses against self-antigens and maintain immune balance.

10
New cards

Which T-helper cells are primarily associated with autoimmune disorders?

Th1 cells.

11
New cards

Main cause of autoimmunity

Loss or breakdown of self-tolerance.

12
New cards

Released sequestered antigens

Autoimmune mechanism in which normally hidden antigens become exposed to the immune system.

13
New cards

Molecular mimicry

Similarity between foreign and self-antigens causes cross-reactivity of immune responses.

14
New cards

Polyclonal B-cell activation

Activation of multiple B-cell clones, potentially promoting autoantibody production.

15
New cards

MHC genes and autoimmunity

Inherited MHC genes are associated with susceptibility to certain autoimmune diseases.

16
New cards

Two classifications of autoimmune diseases

Organ-specific and systemic.

17
New cards

Organ-specific autoimmune disease

Autoimmune disease directed primarily against a particular organ or tissue.

18
New cards

Systemic autoimmune disease

Autoimmune disease affecting multiple organs or tissues.

19
New cards
20
New cards

B. Classification of autoimmune diseases

21
New cards
22
New cards

Hashimoto's thyroiditis

Thyroid.

23
New cards

Graves' disease

Thyroid.

24
New cards

Pernicious anemia

Gastric parietal cells.

25
New cards

Addison's disease

Adrenal glands.

26
New cards

Type I diabetes mellitus

Pancreatic beta cells.

27
New cards

Myasthenia gravis

Nerve-muscle synapses.

28
New cards

Multiple sclerosis

Myelin sheath of nerves.

29
New cards

Autoimmune hemolytic anemia

Red blood cells.

30
New cards

Idiopathic thrombocytopenic purpura

Platelets.

31
New cards

Goodpasture's syndrome

Kidneys and lungs.

32
New cards

Rheumatoid arthritis

Joints, lungs, and skin.

33
New cards

Scleroderma

Skin, gut, lungs, and kidneys.

34
New cards

Systemic lupus erythematosus

Skin, joints, kidneys, brain, heart, and lungs.

35
New cards

Most systemic autoimmune disease in the lecture

Systemic lupus erythematosus.

36
New cards
37
New cards

C. Systemic lupus erythematosus (SLE)

38
New cards
39
New cards

Typical peak age of SLE onset

20–40 years.

40
New cards

Female-to-male susceptibility ratio in SLE

Approximately 10:1.

41
New cards

HLA associations of SLE

HLA-DR2 and HLA-DR3.

42
New cards

Complement deficiencies associated with SLE

C1q, C2, and C4.

43
New cards

Most frequently reported clinical manifestation of SLE

Joint involvement: polyarthralgia or arthritis.

44
New cards

Percentage of SLE patients with joint involvement

Over 90%.

45
New cards

Second most common clinical manifestation of SLE

Skin manifestations.

46
New cards

Classic butterfly rash in SLE

Erythematous rash across the nose and cheeks.

47
New cards

Percentage of SLE patients with butterfly rash

Approximately 30–40%.

48
New cards

UV exposure and SLE

May cause erythematous rashes on exposed areas of the body.

49
New cards

Renal complication of SLE

Glomerulonephritis.

50
New cards

LE cell

Neutrophil that has engulfed the antibody-coated nucleus of another neutrophil.

51
New cards

Important antibody identified in SLE

Anti-DNA antibody.

52
New cards

SLE immunologic abnormality

Uncontrolled autoreactivity of T and B cells leading to autoantibody production.

53
New cards

Possible cause of uncontrolled autoreactivity in SLE

Deficiency of regulatory T cells.

54
New cards

Most common screening test for suspected SLE

Antinuclear antibody (ANA) test.

55
New cards

FANA

Fluorescent antinuclear antibody testing.

56
New cards

FANA sensitivity and positivity in SLE

Approximately 95%; highly sensitive but has low specificity.

57
New cards

Why can't ANA completely rule out SLE?

Approximately 5% of SLE patients may test negative.

58
New cards

ANA limitation

Low diagnostic specificity because other autoimmune diseases may also produce positive results.

59
New cards

Anti-dsDNA

Antibody against double-stranded DNA; associated with SLE.

60
New cards

Anti-dsDNA immunofluorescence pattern

Homogeneous.

61
New cards

Anti-ssDNA

Antibody against single-stranded DNA; associated with SLE and other diseases.

62
New cards

Anti-histone

Antibody against different classes of histones; associated with drug-induced SLE.

63
New cards

Anti-histone immunofluorescence pattern

Homogeneous.

64
New cards

Anti-DNP

Antibody against DNA-histone complex; associated with SLE and drug-induced SLE.

65
New cards

Anti-DNP immunofluorescence pattern

Homogeneous.

66
New cards

Anti-Sm

Antibody against an extractable nuclear antigen containing an RNA component; diagnostic for SLE.

67
New cards

Anti-Sm immunofluorescence pattern

Speckled.

68
New cards

Anti-RNP

Antibody against proteins complexed with nuclear RNA; associated with SLE and mixed connective tissue disease.

69
New cards

Anti-RNP immunofluorescence pattern

Speckled.

70
New cards

Anti-SS-A (Ro)

Antibody against proteins complexed to RNA; associated with SLE and Sjögren's syndrome.

71
New cards

Anti-SS-B (La)

Antibody against phosphoprotein complexed to RNA polymerase; associated with SLE and Sjögren's syndrome.

72
New cards

Anti-SS-A and Anti-SS-B immunofluorescence pattern

Finely speckled.

73
New cards

Anti-nucleolar

Antibody against RNA polymerase and nucleolar proteins.

74
New cards

Anti-nucleolar immunofluorescence pattern

Homogeneous staining of the nucleolus.

75
New cards

Anti-Scl-70

Antibody against DNA topoisomerase I; associated with systemic sclerosis and scleroderma.

76
New cards

Anti-Scl-70 immunofluorescence pattern

Atypical speckled.

77
New cards

Anti-Jo-1

Antibody against histidyl-tRNA synthetase; associated with polymyositis.

78
New cards

Anti-Jo-1 immunofluorescence pattern

Fine cytoplasmic speckling.

79
New cards

Three common FANA patterns

Homogeneous, speckled, and nucleolar.

80
New cards

Antiphospholipid antibodies

Heterogeneous antibodies that bind phospholipids alone or complexed with proteins.

81
New cards

Percentage of lupus patients with antiphospholipid antibodies

Up to 60%.

82
New cards

Lupus anticoagulant

One of the several types of antiphospholipid antibodies.

83
New cards

Coagulation tests prolonged by lupus anticoagulant

APTT and PT, according to the lecture.

84
New cards

Clinical concern associated with antiphospholipid antibodies

Thrombosis and increased risk of spontaneous abortion.

85
New cards
86
New cards

D. Rheumatoid arthritis (RA)

87
New cards
88
New cards

Female-to-male ratio in RA

Approximately 3:1.

89
New cards

Typical age range of RA

35–50 years.

90
New cards

Organs commonly affected by RA

Joints, heart, and lungs.

91
New cards

HLA association of RA

HLA-DR4.

92
New cards

Earliest immunologic finding in rheumatoid joints

Increased synovial lining cells and infiltration of mononuclear cells, mostly CD4+ T lymphocytes.

93
New cards

Pannus

Organized mass of inflammatory cells that grows into the joint space and invades cartilage.

94
New cards

Cells contributing to pannus formation

Macrophages and neutrophils, along with infiltrating immune cells.

95
New cards

Pro-inflammatory cytokines in RA

IL-1, IL-6, IL-8, TNF-alpha, IL-15, and IL-18.

96
New cards

Rheumatoid factor (RF)

Autoantibody found in approximately 75% of RA patients.

97
New cards

Most common immunoglobulin class of rheumatoid factor

IgM.

98
New cards

Target of rheumatoid factor

Fc portion of IgG.

99
New cards

Immune complex in RA

IgM rheumatoid factor combines with IgG.

100
New cards

Hypersensitivity reaction associated with RA immune complexes

Type III hypersensitivity.